The protective effects of the tuberculosis vaccine Bacillus Calmette-Guerin (BCG) on
unrelated infections are thought to be mediated by long-term metabolic changes and …

The Bacillus Calmette-Guérin (BCG) is a live attenuated tuberculosis vaccine that has the
ability to induce non-specific cross-protection against pathogens that might be unrelated to …

BCG vaccination can strengthen protection against pathogens through the induction of
epigenetic and metabolic reprogramming of innate immune cells, a process called trained …

Summary Bacillus Calmette-Guérin (BCG) vaccine is one of the most widely used vaccines
worldwide. In addition to protection against tuberculosis, BCG confers a degree of non …

Bacillus Calmette-Guérin (BCG) is an attenuated Mycobacterium bovis strain used as a
vaccine to prevent Mycobacterium tuberculosis (M. tb) infection. Its ability to potentiate the …

The tuberculosis vaccine bacillus Calmette-Guérin (BCG) protects against some
heterologous infections, probably via induction of non-specific innate immune memory in …

The reason for the largely variable protective effect against TB of the vaccine Bacille
Calmette-Guerin (BCG) is not understood. In this study, we investigated whether epigenetic …

Abstract The Bacillus Calmette-Guérin (BCG) vaccine was discovered a century ago and
has since been clinically applicable. BCG can not only be used for the prevention of …

The live attenuated Mycobacterium bovis strain, Bacille Calmette Guérin (BCG) is a potent
innate immune stimulator. In the C57BL/6 mouse model of tuberculosis, BCG vaccination …

First administered to a human subject as a tuberculosis (TB) vaccine on July 18, 1921,
Bacillus Calmette-Guérin (BCG) has a long history of use for the prevention of TB and later …